Wenju Wu
About Wenju Wu
Wenju Wu is a Senior Principal Scientist at Bristol Myers Squibb with over 20 years of experience in the pharmaceutical industry, including roles at Celgene, Pharmaron, and Johnson & Johnson.
Current Title and Role
Wenju Wu is the Senior Principal Scientist at Bristol Myers Squibb, a prominent pharmaceutical company based in Summit, New Jersey. Since joining the firm in November 2019, he has been instrumental in advancing scientific research and development projects within the organization.
Previous Positions at Celgene
Before his current position, Wenju Wu worked at Celgene as a Principal Scientist from 2014 to 2019. During his tenure of 5 years, he leveraged his extensive scientific expertise to contribute to various research and development initiatives at the company's Summit, NJ location.
Entrepreneurial Experience
Wenju Wu was the Sole Proprietor of Dr. Wu Pharmaforms Solutions from 2012 to 2014. This role allowed him to apply his scientific knowledge and leadership skills in both China and California, USA. The entrepreneurial venture underscores his capability to lead and innovate within the pharmaceutical sector.
Leadership Role at Pharmaron
From 2010 to 2012, Wenju Wu served as the Executive Director of Preformulation & Formulation at Pharmaron based in Beijing, China. In this role, he oversaw critical scientific processes in preformulation and formulation, highlighting his expertise in the field.
Academic Background
Wenju Wu has an academic background stemming from his time as a Research Assistant Professor at SUNY at Buffalo, where he worked from 1997 to 2002. His role in academia helped hone his research skills, which he later applied in pharmaceutical research and development.